Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ono Pharmaceutical
Pharma
Akeso, AstraZeneca, Ono—Fierce Pharma Asia
Akeso's first OS data for its Keytruda challenger caused a violent market reaction. AstraZeneca disclosed another potential fine in China. And more.
Angus Liu
May 2, 2025 7:58am
Takeda, Sun, Ono—Fierce Pharma Asia
Mar 14, 2025 8:45am
Novo Nordisk, AstraZeneca, Ono—Fierce Pharma Asia
Feb 21, 2025 8:45am
FDA approves Ono's rare tumor drug from $2.4B Deciphera buyout
Feb 14, 2025 6:24pm
AstraZeneca-CSPC, Astellas and more—Fierce Pharma Asia
Oct 11, 2024 9:48am
Ono-Deciphera, Novartis-PeptiDream, WuXi Bio—Fierce Pharma Asia
May 3, 2024 7:20am
